EGFR mutations and sensitivity to gefitinib.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15376351)

Published in N Engl J Med on September 16, 2004

Authors

Giulio Rossi, Alessandro Marchioni, Lucia Longo

Articles by these authors

Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol (2003) 2.71

Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration (2014) 2.44

Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases. J Thorac Oncol (2007) 2.00

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer (2007) 1.96

Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol (2004) 1.80

Pulmonary alveolar microlithiasis. N Engl J Med (2002) 1.75

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res (2010) 1.64

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer (2011) 1.62

Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol (2005) 1.50

A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Am J Clin Pathol (2008) 1.48

Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol (2008) 1.44

ERCC1 and small cell lung cancer. J Thorac Oncol (2010) 1.40

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Arch (2012) 1.34

Bronchial typical carcinoid tumors. Semin Thorac Cardiovasc Surg (2006) 1.30

Chickenpox in unexplained pulmonary necrotizing granulomas. Chest (2014) 1.27

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol (2003) 1.23

Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res (2013) 1.22

Kit expression in small cell carcinomas of the lung: effects of chemotherapy. Mod Pathol (2003) 1.10

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer (2011) 1.08

Cryobiopsy and multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Respirology (2015) 1.07

Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma. J Thorac Oncol (2009) 1.07

Gastrointestinal stromal tumor and other primary metachronous or synchronous neoplasms as a suspicion criterion for syndromic setting. Oncol Rep (2010) 1.07

Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens. J Thorac Oncol (2011) 1.07

Benign intratesticular schwannoma: a rare finding. Asian J Androl (2006) 1.06

An unusual case of cystic interstitial lung disease. Lancet (2013) 1.06

ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol (2012) 1.04

Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg (2005) 1.04

Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol (2002) 1.03

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene. Lung Cancer (2012) 1.02

Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas. Am J Surg Pathol (2014) 1.01

Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am J Surg Pathol (2007) 1.00

Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta. Lung Cancer (2008) 1.00

Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol (2014) 1.00

Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis. Lung Cancer (2008) 0.99

Adenocarcinoid tumor of the extrahepatic biliary tract. Int J Surg Pathol (2008) 0.98

Bronchopulmonary actinomycosis associated with hiatal hernia. Mayo Clin Proc (2009) 0.98

The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Lung Cancer (2009) 0.98

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol (2011) 0.97

Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications. PLoS One (2012) 0.96

Idiopathic pulmonary fibrosis: an update. Ann Med (2015) 0.94

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers. Lung Cancer (2009) 0.94

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy. Cancer Sci (2009) 0.94

Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med (2015) 0.94

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer. J Clin Oncol (2009) 0.93

A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J Thorac Oncol (2010) 0.93

Placental transmogrification of the lung: clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells. Hum Pathol (2004) 0.93

Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int (2004) 0.92

Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Sci (2010) 0.92

Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. J Thorac Oncol (2013) 0.92

A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. Anticancer Res (2012) 0.91

EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Am J Clin Pathol (2009) 0.90

Traumatic neuroma of the bronchi: bronchoscopy and histology of a hitherto unreported lesion. Am J Surg Pathol (2008) 0.89

Wanted: lung cancer pathologists. Am J Respir Crit Care Med (2013) 0.89

The role of histology in idiopathic pulmonary fibrosis: an update. Respir Med (2010) 0.89

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer. Expert Rev Anticancer Ther (2011) 0.88

Pulmonary hamartoma associated with typical carcinoid/tumorlet. Virchows Arch (2006) 0.88

Propylthiouracil-induced interstitial pneumonia in a Caucasian woman with amiodarone-induced thyrotoxicosis. Thyroid (2012) 0.88

Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. J Cell Biochem (2011) 0.88

The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg (2004) 0.87

Alveolar adenoma of the lung: a clinicopathologic, immunohistochemical, and molecular study of an unusual case. Int J Surg Pathol (2004) 0.87

HHV-6A in syncytial giant-cell hepatitis. N Engl J Med (2008) 0.86

Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients. Blood (2011) 0.86

Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands. Clin Cancer Res (2013) 0.84

Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol (2011) 0.84

Primary adrenal gland carcinosarcoma associated with metastatic rectal cancer: a hitherto unreported collision tumor. Tumori (2011) 0.84

Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma. Cancer Biol Ther (2007) 0.84

Bronchioloalveolar carcinoma with nodular ("morule-like") features. Virchows Arch (2003) 0.84

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol (2004) 0.83

Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients. PLoS One (2013) 0.83

Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications. Lung Cancer (2011) 0.83

Multi-detection of preservatives in cheeses by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.83

Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma. J Clin Oncol (2011) 0.83

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol (2013) 0.82

"Dry" pleural mesothelioma successfully diagnosed on endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA). Intern Med (2014) 0.82

Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors. Lung Cancer (2012) 0.82

Peribronchial lymph node metastasis from prostate cancer in pulmonary lobectomy for primary lung adenocarcinomas: a possible source of pitfall with therapeutic consequences. Histopathology (2011) 0.82

Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis. Clin Vaccine Immunol (2008) 0.81

PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine. Expert Opin Pharmacother (2013) 0.81

Nodular disease and parafollicular C-cell distribution: results from a prospective and retrospective clinico-pathological study on the thyroid isthmus. Eur J Endocrinol (2009) 0.81

Does primary pulmonary choriocarcinoma really exist? Chest (2003) 0.81

Unusual pathogenesis of spontaneous pneumothorax secondary to Wegener's granulomatosis. Ann Thorac Surg (2007) 0.81

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. Lung Cancer (2006) 0.80

Fishing for ALK with immunohistochemistry may predict response to crizotinib. Tumori (2013) 0.80

Papillary fibroelastoma of the right atrium as an unusual source of recurrent pulmonary embolism. J Cardiovasc Med (Hagerstown) (2006) 0.80

Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications. Expert Rev Clin Immunol (2014) 0.80

Recurrent pleural and pericardium effusions in a white woman with IgG4-related syndrome. Am J Surg Pathol (2009) 0.79